Cargando…
Thromboprophylaxis in COVID-19 – Rationale and considerations
The Corona Virus Disease-2019 (COVID-19) pandemic is associated with a very high incidence of thrombotic complications. The exact mechanisms for this excess risk for clots have not been elucidated although one of the often-quoted pathophysiological entity is immunothrombosis. Recognition of thrombot...
Autores principales: | Bristogiannis, Sotirios, Swan, Dawn, Thachil, Jecko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299150/ https://www.ncbi.nlm.nih.gov/pubmed/34332403 http://dx.doi.org/10.1016/j.jbior.2021.100819 |
Ejemplares similares
-
Non‐factor therapies for bleeding disorders: A primer for the general haematologist
por: Swan, Dawn, et al.
Publicado: (2022) -
Heparin – Messias or Verschlimmbesserung?
por: Swan, Dawn, et al.
Publicado: (2021) -
Practical management of the haemorrhagic complications of myeloproliferative neoplasms
por: Jones, Edward, et al.
Publicado: (2022) -
The versatile heparin in COVID‐19
por: Thachil, Jecko
Publicado: (2020) -
Lessons learnt from COVID‐19 coagulopathy
por: Thachil, Jecko
Publicado: (2021)